Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer-Reference-Cited by-同舟云学术

Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer

Published:2024-09-06 Issue:1 Volume:19 Page:
ISSN:2731-9229
Container-title:Discover Nano
language:en
Short-container-title:Discover Nano

Author:

Oliveira Santos Miguel de Jesus^ORCID,Teles-Souza Jéssica^ORCID,de Araújo-Calumby Renata Freitas^ORCID,Copeland Robert L.^ORCID,Marcelino Henrique Rodrigues^ORCID,Vilas-Bôas Deise Souza^ORCID

Funder

CNPq - National Council for Scientific and Technological Development

Dean of Research/Pro Rectory of Research and Postgraduate Studies (PRPPG)/Federal University of Bahia - UFBA

CAPES

FAPESB - Bahia State Research Funding Institution

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s11671-024-04070-0.pdf

Reference107 articles.

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21492.

2. Omitola OG, Soyele OO, Sigbeku O, et al. A multi-centre evaluation of oral cancer in southern and Western Nigeria: an African oral pathology research consortium initiative. Pan Afr Med J. 2017. https://doi.org/10.11604/pamj.2017.28.64.13089.

3. Bernard WS, Christopher PW (2020) World cancer report 2020.

4. Shylasree TS, Bryant A, Athavale R. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD006246.pub2.

5. Kann BH, Lester-Coll NH, Park HS, et al. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro Oncol. 2016. https://doi.org/10.1093/neuonc/now150.